CIBC Bancorp USA
RMD icon

CIBC Bancorp USA’s ResMed RMD Stock Holding History

CIBC Bancorp USA’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.94M Sell
35,889
-41,150
-53% -$8.98M 0.01% 611
2026
Q2 		$15M Buy
77,039
+26,440
+52% +$5.48M 0.02% 475
2026
Q1 		$11.4M Buy
+50,599
New +$12.6M 0.02% 472
2025
Q3 		$5.53M Buy
+20,207
New +$5.52M 0.03% 384

Other funds holding RMD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

CIBC Bancorp USA's RMD Position: Q3 2026 in Review

CIBC Bancorp USA reduced its ResMed (RMD) stake by 53% in Q3 2026, selling an estimated $8.98M and leaving 35,889 shares worth $7.94M. The position accounts for 0.01% of the portfolio, ranked #611.

CIBC Bancorp USA first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $15M in Q2 2026. 741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • CIBC Bancorp USA held 35,889 shares of ResMed worth $7.94M as of Q3 2026.
  • CIBC Bancorp USA sold 41,150 ResMed shares in Q3 2026, an estimated $8.98M.
  • ResMed made up 0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #611 holding.
  • CIBC Bancorp USA first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's ResMed position peaked at $15M in Q2 2026.
  • 741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.